Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Doctors on Demand

  • Home
  •  
  • Doctors on Demand



  • Most Read
  • Latest Comments
  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    • News

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • BTC Health drives earnings with product diversification to all major hospital operators
    BTC Health drives earnings with product diversification to all major hospital operators
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • News

    From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition

    Bringing pharmaceutical weed to telehealth, medical cannabis company Vitura Health (ASX: VIT) has decided to acquire telehealth company Doctors on Demand for an aggregate consideration of $25 million. This deal includes an upfront cash payment, a deferred cash component, and an equity stake. The acquisition marks Vitura’s leap into new healthcare verticals, including urgent care,

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.